Arcturus Therapeutics Holdings

About Arcturus Therapeutics Holdings

Arcturus is a clinical-stage leader in mRNA. In January 2026, the company achieved a major milestone with the UK MHRA approval of Kostaive (Zapomeran) for COVID-19, marking a historic step for self-amplifying mRNA (sa-mRNA) technology globally.